Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FBSB0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,602
Award facts
- Contract value 100% obligated
- $12,602.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,602.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pen injectors on November 18, 2025, with completion expected by November 19, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The contract is classified as a child order under this larger IDC vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and related government entities.
This delivery order reflects ongoing pharmaceutical procurement patterns within the DLA's medical supply chain operations, which leverage AmerisourceBergen's extensive inventory of brand-name and generic medications across multiple therapeutic domains. The Zepbound supply supports federal healthcare programs' pharmaceutical needs through AmerisourceBergen's established distribution capabilities. As a major contractor under the DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen maintains competitive positioning to fulfill federal medical supply requirements across diverse product categories and therapeutic areas in support of military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FBSB0?
SPE2DR26FBSB0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FBSB0 worth?
The government has obligated $12,602 on SPE2DR26FBSB0.
Is contract SPE2DR26FBSB0 an order under another contract?
Yes. SPE2DR26FBSB0 is a delivery order under SPE2DR25D2002, an indefinite delivery contract.
Was contract SPE2DR26FBSB0 competed?
The extent of competition for SPE2DR26FBSB0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award